Andrew Obenshain
2021
In 2021, Andrew Obenshain earned a total compensation of $9.3M as Chief Executive Officer at bluebird bio.
Compensation breakdown
| Non-Equity Incentive Plan | $345,313 |
|---|---|
| Option Awards | $5,426,581 |
| Salary | $485,615 |
| Stock Awards | $2,988,568 |
| Other | $11,925 |
| Total | $9,258,001 |
Obenshain received $5.4M in option awards, accounting for 59% of the total pay in 2021.
Obenshain also received $345.3K in non-equity incentive plan, $485.6K in salary, $3M in stock awards and $11.9K in other compensation.
Rankings
In 2021, Andrew Obenshain's compensation ranked 1,178th out of 12,415 executives tracked by ExecPay. In other words, Obenshain earned more than 90.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,178 out of 12,415 | 91st |
Division Manufacturing | 414 out of 5,505 | 93rd |
Major group Chemicals And Allied Products | 150 out of 2,375 | 94th |
Industry group Drugs | 125 out of 2,096 | 94th |
Industry Biological Products, Except Diagnostic Substances | 36 out of 449 | 92nd |
Source: SEC filing on May 2, 2022.
Obenshain's colleagues
We found six more compensation records of executives who worked with Andrew Obenshain at bluebird bio in 2021.
2021
Nick Leschly
bluebird bio
Chief Executive Officer
2021
Jason Cole
bluebird bio
Chief Business Officer
2021
Gina Consylman
bluebird bio
Chief Financial Officer
2021
William Baird
bluebird bio
Chief Financial Officer
2021
Philip Gregory
bluebird bio
Chief Scientific Officer
2021
Thomas Klima
bluebird bio